What men want: Qualitative analysis of what men with prostate cancer (PCa) want to learn regarding genetic referral, counseling, and testing
- PMID: 32027768
- PMCID: PMC8195313
- DOI: 10.1002/pros.23959
What men want: Qualitative analysis of what men with prostate cancer (PCa) want to learn regarding genetic referral, counseling, and testing
Abstract
Background: Guidelines have changed recently to include genetic counseling (GC) and/or genetic testing (GT) for all men with aggressive prostate cancer (PCa). This study aimed to identify what information men with PCa desire before and from GC.
Methods: Focus groups were conducted with men who have PCa. Audio recordings were analyzed for themes related to GT, the information they desired from health care providers, and implications for family members.
Results: Thirty-seven men with PCa participated in seven focus groups. Nearly all men felt GT was beneficial and impactful for their family and themselves. Most men were unaware of the risks to female relatives associated with hereditary cancer. Participants discussed that genetics should be incorporated at an appropriate time of their diagnostic journey.
Conclusion: This study showed that men valued GC and GT for personal and familial implications, and often did not associate PCa genetics with risk for female relatives to develop cancer. Consideration should be given to the GC timing in regard to where men are in their treatment process. Providers referring patients can leverage patient motivations and utilize their relationship with the patient to determine the appropriate timing and personalize discussion with the patient regarding GC and GT.
Keywords: BRCA1/2; genetic counseling; germline mutations; prostate cancer genetics.
© 2020 Wiley Periodicals, Inc.
Conflict of interest statement
CONFLICT OF INTERESTS
The authors declare that there are no conflicts of interests.
Similar articles
-
Pretest Genetic Education Video Versus Genetic Counseling for Men Considering Prostate Cancer Germline Testing: A Patient-Choice Study to Address Urgent Practice Needs.JCO Precis Oncol. 2021 Sep 1;5:PO.21.00238. doi: 10.1200/PO.21.00238. eCollection 2021. JCO Precis Oncol. 2021. PMID: 34589662 Free PMC article.
-
Understanding of multigene test results among males undergoing germline testing for inherited prostate cancer: Implications for genetic counseling.Prostate. 2018 Sep;78(12):879-888. doi: 10.1002/pros.23535. Epub 2018 Apr 14. Prostate. 2018. PMID: 29655297 Free PMC article.
-
Clinical Implications of Germline Testing in Newly Diagnosed Prostate Cancer.Eur Urol Oncol. 2021 Feb;4(1):1-9. doi: 10.1016/j.euo.2020.11.011. Epub 2020 Dec 31. Eur Urol Oncol. 2021. PMID: 33390340 Review.
-
TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing.JCO Precis Oncol. 2024 Mar;8:e2300552. doi: 10.1200/PO.23.00552. JCO Precis Oncol. 2024. PMID: 38452310 Free PMC article. Clinical Trial.
-
Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.J Clin Oncol. 2020 Aug 20;38(24):2798-2811. doi: 10.1200/JCO.20.00046. Epub 2020 Jun 9. J Clin Oncol. 2020. PMID: 32516092 Free PMC article.
Cited by
-
Clinical Germline Testing Results of Men With Prostate Cancer: Patient-Level Factors and Implications of NCCN Guideline Expansion.JCO Precis Oncol. 2021 Mar 23;5:PO.20.00432. doi: 10.1200/PO.20.00432. eCollection 2021. JCO Precis Oncol. 2021. PMID: 34250421 Free PMC article.
-
"Hope at a better chance": perspectives on genetic counseling and testing among black individuals with prostate cancer.J Community Genet. 2025 Jun;16(3):335-349. doi: 10.1007/s12687-025-00785-4. Epub 2025 Mar 17. J Community Genet. 2025. PMID: 40095207 Free PMC article.
-
Practical Considerations and Challenges for Germline Genetic Testing in Patients With Prostate Cancer: Recommendations From the Germline Genetics Working Group of the PCCTC.JCO Oncol Pract. 2020 Dec;16(12):811-819. doi: 10.1200/OP.20.00431. Epub 2020 Sep 28. JCO Oncol Pract. 2020. PMID: 32986533 Free PMC article. Review.
-
Population-Level Patterns of Prostate Cancer Occurrence: Disparities in Virginia.Curr Mol Biol Rep. 2022 Mar;8(1):1-8. doi: 10.1007/s40610-022-00147-w. Epub 2022 Mar 11. Curr Mol Biol Rep. 2022. PMID: 35909818 Free PMC article.
-
Insight into how patients with prostate cancer interpret and communicate genetic test results: implications for families.J Community Genet. 2022 Dec;13(6):547-556. doi: 10.1007/s12687-022-00603-1. Epub 2022 Jul 22. J Community Genet. 2022. PMID: 35869324 Free PMC article.
References
-
- Howlader NNA, Krapcho M, Miller D, et al. SEER Cancer Statistics Review, 1975-2016. Bethesda, MD: National Cancer Institute; 2017. https://seer.cancer.gov/csr/1975_2015/
-
- Chamie K, deVere White RW, Lee D, Ok J, Ellison LM. Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer. Cancer. 2008;113(9):2464–2470. - PubMed
-
- Grönberg H. Prostate cancer epidemiology. The Lancet. 2003; 361(9360):859–864. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous